New York Presbyterian Hospital-Columbia University Medical Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Presbyterian Hospital-Columbia University Medical Center has participated in 12 clinical trials with 7 currently active.
Therapeutic areas: Advanced Cancer, Endometrial Adenocarcinoma, GBA1 Parkinson Disease.
Sponsors: RAPT Therapeutics, Inc., Acrivon Therapeutics, Capsida Biotherapeutics, Inc..
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Presbyterian Hospital-Columbia University Medical Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Presbyterian Hospital-Columbia University Medical Center has 12 clinical trials on record, with 7 currently active. Their work covers Advanced Cancer, Endometrial Adenocarcinoma, GBA1 Parkinson Disease.
Yes — New York Presbyterian Hospital-Columbia University Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.